BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16490956)

  • 1. Managing partnerships and impact on decision-making: the example of health technology assessment in genetics.
    Blancquaert I
    Community Genet; 2006; 9(1):27-33. PubMed ID: 16490956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Authority for Health: France.
    Rochaix L; Xerri B
    Issue Brief (Commonw Fund); 2009 Jul; 58():1-9. PubMed ID: 19639712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of health technology assessment recommendations into organizational and clinical practice: A case study in Catalonia.
    Gagnon MP; Sánchez E; Pons JM
    Int J Technol Assess Health Care; 2006; 22(2):169-76. PubMed ID: 16571192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment and public health: a time for convergence.
    Battista RN; Lafortune L
    Eur J Public Health; 2009 Jun; 19(3):227. PubMed ID: 19380330
    [No Abstract]   [Full Text] [Related]  

  • 5. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-user involvement in health technology assessment (HTA) development: a way to increase impact.
    McGregor M; Brophy JM
    Int J Technol Assess Health Care; 2005; 21(2):263-7. PubMed ID: 15921068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an alternative to a National Health Board for Technology Assessment?
    Lerner JC
    Med Interface; 1994 Jun; 7(6):123-6, 132. PubMed ID: 10135316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health care technology adoption and diffusion in a social context.
    Coyte PC; Holmes D
    Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of health technology assessment in decision making: coresponsibility of users and producers?
    Hivon M; Lehoux P; Denis JL; Tailliez S
    Int J Technol Assess Health Care; 2005; 21(2):268-75. PubMed ID: 15921069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.
    Xie F; Bowen JM; Sutherland SC; Burke N; Blackhouse G; Tarride JE; O'Reilly D; Goeree R
    Expert Rev Pharmacoecon Outcomes Res; 2011 Oct; 11(5):513-21. PubMed ID: 21958096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A statewide strategy for nursing workforce development through partnerships in Texas.
    Kishi A; Green A
    Policy Polit Nurs Pract; 2008 Aug; 9(3):210-4. PubMed ID: 18515787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment and the regulation of medical devices and procedures in Quebec. Synergy, collusion, or collision?
    Battista RN; Lance JM; Lehoux P; Régnier G
    Int J Technol Assess Health Care; 1999; 15(3):593-601. PubMed ID: 10874385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NICE's use of cost effectiveness as an exemplar of a deliberative process.
    Culyer AJ
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy decision-making under scientific uncertainty: radiological risk assessment and the role of expert advisory groups.
    Mossman KL
    Health Phys; 2009 Aug; 97(2):101-6. PubMed ID: 19590269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint project of the International Network of Agencies for Health Technology Assessment--Part 2: Managing the diffusion of positron emission tomography with health technology assessment.
    Adams EJ; Almazán C; Mørland B; Bradbury I; King R; Rheinberger P
    Int J Technol Assess Health Care; 2006; 22(2):149-54. PubMed ID: 16571189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
    Lopert R
    Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of science in policy making--EuSANH-ISA project, framework for science advice for health].
    Cianciara D; Piotrowicz M; Bielska-Lasota M; Wysocki MJ
    Przegl Epidemiol; 2012; 66(3):521-9. PubMed ID: 23230726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is technology assessment?
    Banta D
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():7-9. PubMed ID: 19519979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.